Repurposing Licensed Drugs with Activity Against Epstein–Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach: Anti-EBV Drugs for MS

Get it

Li, Vivien, McKay, Fiona C., Tscharke, David C., Smith, Corey, Khanna, Rajiv, Lechner-Scott, Jeannette, Rawlinson, William D., Lloyd, Andrew R., Taylor, Bruce V., Morahan, Julia M., Steinman, Lawrence, Giovannoni, Gavin, Bar-Or, Amit, Levy, Michael, Drosu, Natalia, Potter, Andrew, Caswell, Nigel, Smith, Lynne, Brady, Erin C., Frost, Bruce, Hodgkinson, Suzanne, Hardy, Todd A., Broadley, Simon A.

CNS Drugs. 39(3):305-320

Saved in:

Bibliographic Details
Title	Repurposing Licensed Drugs with Activity Against Epstein–Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach: Anti-EBV Drugs for MS
Authors	Li, Vivien, McKay, Fiona C., Tscharke, David C., Smith, Corey, Khanna, Rajiv, Lechner-Scott, Jeannette, Rawlinson, William D., Lloyd, Andrew R., Taylor, Bruce V., Morahan, Julia M., Steinman, Lawrence, Giovannoni, Gavin, Bar-Or, Amit, Levy, Michael, Drosu, Natalia, Potter, Andrew, Caswell, Nigel, Smith, Lynne, Brady, Erin C., Frost, Bruce, Hodgkinson, Suzanne, Hardy, Todd A., Broadley, Simon A.
Source	CNS Drugs. 39(3):305-320

Holdings